Hyperinsulinemia can also upregulate hepatic lipogenesis via the insulin-Akt-mTOR signaling pathway, which can contribute to hepatic steatosis and a further decrease in insulin clearance [27]. The gene discussed is MTOR; the disease is fatty liver disease.